Perturb 2026

CRISPR screens have become a primary discovery engine in modern biology as well as a key tool in drug discovery. This conference features technologies that link CRISPR perturbation screens to high-content read-outs.

Join Myllia at Perturb 2026 – the first high-content CRISPR screening conference

Visit Perturb 2026 for more information
Register here until February 15, 2026

Scientific Themes

– CRISPR-based screening strategies
– Perturb-Seq & CROP-Seq methodologies
– Computational analysis and data interpretation
– AI models of human cells
– Imaging-based CRISPR screens

Confirmed Speakers (in alphabetical order)

Christoph Bock (CeMM & Medical University of Vienna)
Thijn Brummelkamp (NKI Amsterdam)
Silvia Domcke (University of Zurich)
Samouil Farhi (Broad Institute)
Mathew Garnett (Wellcome Sanger Institute)
Luke Gilbert (Arc Institute & UCSF)
Francesco Iorio (Human Technopole)
Xin Jin (Scripps Research Institute)
Wei Li (University of Maryland)
Prisca Liberali (FMI Basel)
Mo Lotfollahi (Wellcome Sanger Institute)
Andreas E. Moor (ETH Zurich)
Thomas Norman (MSKCC)
Leopold Parts (Wellcome Sanger Institute)
Radu Rapiteanu (GSK)
Yusuf Roohani (Arc Institute)
Rahul Satija (New York Genome Center)
Jonathan Schmid-Burgk (University of Bonn)
Jake Taylor-King (Relation Therapeutics)
Johannes Zuber (IMP Vienna)